Clinical Trial Update: Pembrolizumab in Combination With CRT for LA-SCCHN [Phase 1]

View source ↗

Summary

Phase 1 study evaluating pembrolizumab in combination with chemoradiotherapy for locally advanced head and neck squamous cell carcinoma has completed enrollment…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma
• Hypopharyngeal Cancer
• Laryngeal Cancer
• Oral Cavity Cancer
• Oropharyngeal Cancer

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: Sanford Health | Conditions: Head and Neck Cancer, Squamous Cell Carcinoma | Phase 1 | Status: COMPLETED | Results posted: 2021-01-15